Pneumonitis in advanced non-small-cell lung cancer (NSCLC) patients (pts) treated with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI): Meta-analysis of 153 trial cohorts with 15,713 pts.

Kinase Inhibitor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Efficacy of Afatinib, Erlotinib, and Gefitinib on epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) patients with brain metastasis: a network meta-analysis

10.1183/13993003.congress-2018.pa2802 ◽

2018 ◽

Author(s):

So-My Koo ◽

Ki-Up Kim ◽

Yang-Ki Kim ◽

Soo-Taek Uh

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Mutant ◽

Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer?

The Korean Journal of Internal Medicine ◽

10.3904/kjim.2016.190 ◽

2017 ◽

Vol 32 (3) ◽

pp. 422-428 ◽

Cited By ~ 1

Author(s):

Yong Won Choi ◽

Jin-Hyuk Choi

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Egfr Mutation ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth

Clinical Significance of Sequential Treatment with Afatinib in the Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Treatment of Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3935 ◽

2019 ◽

Author(s):

N. Kobayashi ◽

H. Aiko ◽

C. Kamimaki ◽

N. Mikami ◽

S. Kubo ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Tki Treatment ◽

Egfr Mutant

Plasma ctDNA monitoring during epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor treatment in patients with EGFR-mutant non-small cell lung cancer (JP-CLEAR trial)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyz023 ◽

2019 ◽

Vol 49 (6) ◽

pp. 554-558 ◽

Cited By ~ 5

Author(s):

Kazuhiro Usui ◽

Takuma Yokoyama ◽

Go Naka ◽

Hiroo Ishida ◽

Kazuma Kishi ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Mutant ◽

Inhibitor Treatment

First-line gefinitib (G) for advanced non-small cell lung cancer (NSCLC) patients (pts) harboring sensitizing epidermal growth factor receptor mutations (EGFR-M+): Meta-analysis of randomized trials (RCT) exploring the magnitude of benefits over chemotherapy (CT).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e18076 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e18076-e18076

Author(s):

D. Giannarelli ◽

E. Bria ◽

M. Milella ◽

F. Cuppone ◽

A. Ceribelli ◽

...

Keyword(s):

Lung Cancer ◽

Randomized Trials ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Epidermal Growth ◽

Case Report: A Rare Epidermal Growth Factor Receptor (EGFR) H773L/V774M Compound Mutation in Advanced Non-Small Cell Lung Cancer with Poor Response to EGFR Tyrosine Kinase Inhibitor

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6993 ◽

2019 ◽

Author(s):

L.-C. Chen ◽

C.-Y. Yang

Keyword(s):

Lung Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Poor Response ◽

Small Cell ◽

Small Cell Lung ◽

Compound Mutation ◽

Epidermal Growth

76: Patterns of extra-cranial disease progression in epidermal growth factor receptor (EGFR) mutant metastatic non-small cell lung cancer (NSCLC) patients on a tyrosine kinase inhibitor (TKI)

Lung Cancer ◽

10.1016/s0169-5002(15)50075-5 ◽

2015 ◽

Vol 87 ◽

pp. S30 ◽

Cited By ~ 3

Author(s):

K. Aitken ◽

S. Popat ◽

C. Nutting ◽

F. McDonald

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Mutant ◽

148P Neutrophil to lymphocyte ratio as a prognostic factor in epidermal growth factor receptor-mutant non-small cell lung cancer treated with tyrosine kinase inhibitor: A systematic review and meta-analysis

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(21)01990-0 ◽

2021 ◽

Vol 16 (4) ◽

pp. S778

Author(s):

R.S. Heriyanto ◽

J. Tandiono ◽

E. Marcella ◽

B. Susanto ◽

S. Chen ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Kinase Inhibitor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Receptor Mutant

A meta-analysis of the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor treatment in non-small-cell lung cancer patients.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e20604 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e20604-e20604

Author(s):

Hongmei Xu ◽

Kaitlyn Minchella ◽

Diansong Zhou ◽

Nidal Al-Huniti

Keyword(s):

Lung Cancer ◽

Kinase Inhibitor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Inhibitor Treatment

A Study of Tepotinib Plus Osimertinib in Epidermal Growth Factor Receptor (EGFR ) Tyrosine Kinase Inhibitor (TKI) Relapsed Mesenchymal-epithelial Transition Factor (MET) Amplified Non-small Cell Lung Cancer (NSCLC)

Case Medical Research ◽

10.31525/ct1-nct03940703 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Mesenchymal Epithelial Transition Factor ◽

Mesenchymal Epithelial Transition